Glucose Tolerance Study

Exclusion Criteria

• •Unstable or serious illness (e.g. Serious mood disorders, neurological disorders such as MS, kidney disease, liver disease, heart conditions, thyroid gland dysfunction)
• •Known diabetes (Type I or II), or impaired glucose tolerance
• •Fasting glucose ≥5.6 mmol/L or known random glucose ≥11.1 mmol/L
• •Use of medications that affect glucose metabolism (e.g., corticosteroids, beta-blockers, diuretics).
• •Current malignancy (excluding BCC) or chemotherapy and radiotherapy treatment for malignancy within the previous 2 years
• •Active smokers, nicotine use, alcohol or drug (prescription or illegal substances) abuse
• •Chronic past and/or current alcohol use (\>14 alcoholic drinks week)
• •Allergic to any of the ingredients in the active or placebo formula
• •Consistently (3 or more days per week) taken OEA within the past 4 weeks
• •Known pregnant or lactating woman
• •Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion
• •Participants who have participated in any other non-RDC related clinical study during the past 1 month
• •Recent infection or trauma in the month prior to the study or on the days of the clinic visits